BI-Sifrol Tablets [pramipexole] Special Drug Use Surveillance (Survey on the Safety and Efficacy in Parkinson's Disease Patients With Depressive Symptoms).

Trial Profile

BI-Sifrol Tablets [pramipexole] Special Drug Use Surveillance (Survey on the Safety and Efficacy in Parkinson's Disease Patients With Depressive Symptoms).

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Sep 2014

At a glance

  • Drugs Pramipexole (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 04 Nov 2009 Actual patient number (1087) added as reported by ClinicalTrials.gov.
    • 04 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Jul 2009 Planned end date changed from 1 Jun 2009 to 1 Sep 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top